Besides, we propose targeted glycoproteomics of important E-selectin ligands, e.g., ESL-1, PSGL-1, and CD44, to further broaden our understanding of the regulation and importance of the sLex/a—E-selectin axis in AML. This evidence concerns the gene SELPLG and acute myeloid leukemia.